文献速递艾滋病与性传播感染

干血斑中恩曲他滨三磷酸可预测HIV病毒抑制并反映短期服药依从性

Emtricitabine triphosphate in dried blood spots is a predictor of viral suppression in HIV infection and reflects short-term adherence to antiretroviral therapy.
PubMed 文献 · J Antimicrob Chemother · 2019-01-01

结果显示,可定量FTC-TP与病毒抑制的校正比值比为7.2(95%CI 4.3-12.0;P<0.0001),进一步校正替诺福韦二磷酸后为2.1(95%CI 1.2-4.0;P=0.015)。3天自我报告依从性预测可定量FTC-TP的ROC曲线下面积为0.82(95%CI 0.75-0.88)。

要点

  • 干血斑FTC-TP可定量者病毒抑制的aOR为7.2(95%CI 4.3-12.0;P<0.0001)。
  • 进一步校正替诺福韦二磷酸后,aOR为2.1(95%CI 1.2-4.0;P=0.015)。
  • 3天自我报告依从性预测FTC-TP的AUC为0.82(95%CI 0.75-0.88)。

核心结论

  • 在HIV感染者中,干血斑FTC-TP是病毒抑制的强预测因子,即使校正替诺福韦二磷酸后仍显著。
  • 3天自我报告依从性对可定量FTC-TP的预测能力最佳。

研究设计与样本

  • 在常规临床访视时采集干血斑和HIV病毒载量,并收集3天、30天和3个月自我报告依从性。
  • 采用广义估计方程估算病毒抑制的校正比值比(aOR),用ROC曲线下面积评估自我报告依从性预测FTC-TP的效用。

主要发现

  • 可定量FTC-TP相比低于定量下限(BLQ),病毒抑制的aOR为7.2(95%CI 4.3-12.0;P<0.0001),校正年龄、性别、种族、BMI、ART类别、ART时长、eGFR和CD4+ T细胞计数。
  • 进一步校正替诺福韦二磷酸后,aOR为2.1(95%CI 1.2-4.0;P=0.015)。
  • 3天自我报告依从性预测可定量FTC-TP的AUC为0.82(95%CI 0.75-0.88),30天为0.79(95%CI 0.71-0.86,P=0.32),3个月为0.70(95%CI 0.62-0.77,P=0.004)。

临床怎么用

  • 干血斑FTC-TP可作为评估HIV感染者病毒抑制风险的客观生物标志物。
  • 询问3天自我报告依从性有助于快速识别FTC-TP可定量可能性较高的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Emtricitabine triphosphate (FTC-TP), the phosphorylated anabolite of emtricitabine, can be quantified in dried blood spots (DBS). We evaluated FTC-TP in DBS as a predictor of viral suppression and evaluated self-reported adherence as a predictor of FTC-TP. METHODS: Persons living with HIV (PLWH) on an FTC-containing regimen were prospectively recruited. A DBS and HIV viral load were obtained during routine clinical visits. Self-reported adherence for 3 days, 30 days and 3 months was captured. Generalized estimating equations were used to estimate the adjusted odds ratio (aOR) of viral suppression for quantifiable FTC-TP versus below the limit of quantification (BLQ). The utility of self-reported adherence to predict quantifiable FTC-TP was assessed by calculating the area under receiver operating characteristic (ROC) curve. RESULTS: One thousand one hundred and fifty-four person-visits from 514 participants who had DBS assayed for FTC-TP were included in the analysis. After adjusting for age, gender, race, BMI, ART class, ART duration, estimated glomerular filtration rate and CD4+ T cell count, the aOR (95% CI) for viral suppression for quantifiable FTC-TP versus BLQ was 7.2 (4.3-12.0; P < 0.0001). After further adjusting for tenofovir diphosphate, the aOR was 2.1 (1.2-4.0; P < 0.015). The area under the ROC curve for 3 day self-reported adherence was 0.82 (95% CI 0.75-0.88) compared with 0.70 (95% CI 0.62-0.77, P = 0.004) and 0.79 (95% CI 0.71-0.86, P = 0.32) for 3 month and 30 day self-reported adherence, respectively. CONCLUSIONS: In PLWH, FTC-TP from DBS is a strong predictor of viral suppression, even after adjusting for tenofovir diphosphate, and was best predicted by 3 day self-reported adherence.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Frasca K, Morrow M, Coyle RP, et al. Emtricitabine triphosphate in dried blood spots is a predictor of viral suppression in HIV infection and reflects short-term adherence to antiretroviral therapy. J Antimicrob Chemother. 2019. PMID: 30668713. doi:10.1093/jac/dky559

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。